Andreas Bueltmann

Andreas Bueltmann has worked in the science and innovation field for over two decades. In 2022, they began their current role as Senior Director Science & Innovation at iOmx Therapeutics AG. Prior to this, they held the position of CSO at Corimmun GmbH from 2007 to 2021. From 2007 to 2021, they also worked at MorphoSys in various roles, including Senior Director, Team Leader Discovery Biology, Senior Director, Team Leader Research Project Initiation, Senior Director, Leader Discovery Programs, Director - Leader Discovery Project R&D and Sourcing, Director R&D Sourcing, Associate Director R&D Sourcing, Technology Scout, Associate Director, Technology Scout, Senior Scientist, and Target Scout, Senior Scientist. From 2000 to 2021, they were Director of Molecular Research at Trigen GmbH and PostDoc at DHZ M\u00fcnchen.

Andreas Bueltmann obtained their Dipl. Biol. in Microbiology from the University of M\u00fcnster between 1988 and 1994. Andreas then attended Heidelberg University from 1994 to 1996, studying Virology. Finally, they obtained their Dr. in Virology from Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen between 1996 and 2000.